Moderna Biopharma Canada Corporation
Registration:
1
of
2
(2026-03-06
to
2026-03-06)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Communicating with Government in general about pharmaceutical and biotechnology policies, including those related to innovation, R&D and messenger ribonucleic acid (mRNA) biotechnology. Communicating with government for policies around RSV Vaccines for British Columbians.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
COVID-19, Finances and Budgets, Health, Hospitals, Senior Citizens
|